GRIFOLS traded at 19.83 this Friday May 27th, decreasing 0.07 or 0.33 percent since the previous trading session. Looking back, over the last four weeks, GRIFOLS lost 19.78 percent. Over the last 12 months, its price fell by 13.22 percent. Looking ahead, we forecast GRIFOLS to be priced at 19.17 by the end of this quarter and at 17.39 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
19.83
Daily Change
-0.33%
Yearly
-13.22%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Alcon AG 70.74 0.94 1.35% 12.93%
Almirall SA 10.47 -0.02 -0.19% -25.27%
Amarin 1.44 0.01 0.70% -68.28%
Amadeus IT 60.02 0.70 1.18% -3.19%
argenx SE 295.10 1.40 0.48% 28.03%
Artemis Alpha 310.00 -6.00 -1.90% -31.87%
AstraZeneca 10,474.00 -72.00 -0.68% 30.18%
Bayer 66.49 0.59 0.90% 27.28%
Cie Automotive 23.40 0.48 2.09% -4.72%
Essilor 152.95 4.50 3.03% 7.27%
Ence Energia y Celulosa SA 3.61 -0.01 -0.17% 4.28%
Ferrovial 24.20 0.06 0.25% 0.96%
Fresenius Medical Care 56.58 -0.10 -0.18% -13.99%
Fresenius 32.52 0.34 1.06% -27.18%
Genmab 2,138.00 14.00 0.66% -12.12%
Galapagos 52.90 0.48 0.92% -15.76%
GRIFOLS 19.83 -0.07 -0.33% -13.22%
GlaxoSmithKline 1,738.00 -15.80 -0.90% 29.30%
Hikma Pharmaceutical 1,702.00 -2.00 -0.12% -30.36%
Inditex 22.27 0.62 2.86% -30.23%
H Lundbeck A/S 162.50 0.15 0.09% -17.97%
Merck 178.45 3.05 1.74% 20.90%
Novartis 86.92 -0.90 -1.02% 8.66%
Philips 23.69 0.02 0.06% -48.89%
Roche Holding 328.20 -4.80 -1.44% 4.79%
Sanofi 102.28 -1.32 -1.27% 16.28%
Smith & Nephew PLC 1,303.50 -1.00 -0.08% -15.38%
UCB 81.88 -0.78 -0.94% 8.22%
Viscofan 50.60 0.35 0.70% -12.53%
William Demant Holding 282.70 -3.50 -1.22% -10.08%

Indexes Price Day Year
ES35 8934 44.80 0.50% -3.15%

GRIFOLS
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.